Jasper Therapeutics Files 8-K
Ticker: JSPRW · Form: 8-K · Filed: Jun 16, 2025 · CIK: 1788028
| Field | Detail |
|---|---|
| Company | Jasper Therapeutics, Inc. (JSPRW) |
| Form Type | 8-K |
| Filed Date | Jun 16, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-disclosure, financial-statements, stock-information
Related Tickers: JSPR
TL;DR
Jasper Therapeutics filed an 8-K on 6/14/25 covering stock and warrants.
AI Summary
On June 14, 2025, Jasper Therapeutics, Inc. filed an 8-K report detailing other events and financial statements. The company, formerly known as Amplitude Healthcare Acquisition Corp, is incorporated in Delaware and operates in the biological products sector. The filing includes information on voting common stock and redeemable warrants.
Why It Matters
This 8-K filing provides an update on Jasper Therapeutics' corporate structure and financial instruments, which is important for investors tracking the company's status.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant new risks.
Key Players & Entities
- Jasper Therapeutics, Inc. (company) — Registrant
- Amplitude Healthcare Acquisition Corp (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- June 14, 2025 (date) — Date of earliest event reported
FAQ
What is the exact date of the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing is June 14, 2025.
What was Jasper Therapeutics, Inc. formerly known as?
Jasper Therapeutics, Inc. was formerly known as Amplitude Healthcare Acquisition Corp.
In which state is Jasper Therapeutics, Inc. incorporated?
Jasper Therapeutics, Inc. is incorporated in Delaware.
What is the SIC code for Jasper Therapeutics, Inc.?
The SIC code for Jasper Therapeutics, Inc. is 2836, which corresponds to BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).
What are the two main items reported in this 8-K filing?
This 8-K filing reports on 'Other Events' and 'Financial Statements and Exhibits'.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 16, 2025 regarding Jasper Therapeutics, Inc. (JSPRW).